A5007817412- Antibiotic Use and Resistance
- Neutropenia and Cancer Infections
- Nosocomial Infections in ICU
- Vitamin D Research Studies
- COVID-19 Clinical Research Studies
- Reproductive tract infections research
- Pneumonia and Respiratory Infections
- Esophageal and GI Pathology
- Chemotherapy-related skin toxicity
- Syphilis Diagnosis and Treatment
- Nausea and vomiting management
- Body Image and Dysmorphia Studies
- Infection Control in Healthcare
- ECG Monitoring and Analysis
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrhythmias and Treatments
- Sepsis Diagnosis and Treatment
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Geriatric Care and Nursing Homes
- Antibiotics Pharmacokinetics and Efficacy
- Vitamin C and Antioxidants Research
University of St. Gallen
2022-2025
University Hospital of Bern
2020
University of Bern
2020
Abstract Background The coronavirus disease 19 (COVID-19) pandemic has caused millions of deaths, and new treatments are urgently needed. Factors associated with a worse COVID-19 prognosis include old age (> 65 years), ethnicity, male sex, obesity, people comorbidities. Furthermore, vitamin D deficiency was reported as predictor poor in patients acute respiratory failure due to COVID-19. According recent clinical case series, is modifiable risk factor, which the prospect reducing hospital...
We present a case of tabes dorsalis with delayed diagnosis in carpenter who presented VIth cranial nerve palsy, decreased deep tendon reflexes, reduced sense vibration and an unsteady gait. After deterioration symptoms almost complete loss vision due to bilateral optic atrophy, pronounced relative afferent pupillary defect severe gait ataxia, 4 years extensive diagnostic testing ineffective treatments, including several MRIs, genetic analysis eye surgeries, serological was positive for...
Vitamin D and its role in the coronavirus-19 disease (COVID-19) pandemic has been controversially discussed, with inconclusive evidence about vitamin D3 (cholecalciferol) supplementation COVID-19 patients. metabolites play an important initiation of immune response can be easily modifiable risk factor 25-hydroxyvitamin (25(OH)D3)-deficient This is a multicenter, randomized, placebo-controlled double-blind trial to compare effect single high dose followed by treatment as usual (TAU) daily...
Abstract Background The coronavirus disease 2019 (COVID-19) pandemic led to a global increase in healthcare-associated infections (HAI) among intensive care unit (ICU) patients. Whether this is directly attributable COVID-19 or whether the indirectly (via staff shortages breaches infection prevention measures) increase, remains unclear. objectives of study were assess HAI incidence and identify independent risk factors for non-COVID-19 ICU Methods We established monocentric prospective...
Shortening the duration of antibiotic therapy (DAT) for common infectious diseases may be an effective strategy to tackle antimicrobial resistance. Shorter DAT has been proven safe and community-acquired pneumonia (CAP), cellulitis, cholangitis.In a retrospective multicentre quality-control study, medical records 770 patients hospitalized with CAP, cholangitis at three tertiary care hospitals in Switzerland during 2017-2018 were randomly selected. Appropriateness treatment was assessed...
Prophylaxie et traitement chez les patients hémato-oncologiques SARS-COV-2 Les atteints d'une maladie hémato-oncologique font partie des plus à risque de développer un COVID-19 sévère [1, 2].De plus, outre le accru sévère, ils peuvent présenter une infection prolongée par SARS-CoV-2 avec excrétion longue du virus [3].La prophylaxie précoce revêtent dès lors grande importance ces patients.